Literature DB >> 17904074

Do high-density lipoprotein cholesterol levels influence stroke severity?

Nerses Sanossian1, Jeffrey L Saver, Doojin Kim, Tannaz Razinia, Bruce Ovbiagele.   

Abstract

BACKGROUND: Low-serum high-density lipoprotein (HDL) cholesterol levels are associated with increased risk of stroke in various populations, including young patients. Severity of stroke is an important determinant of outcome and may be affected by baseline HDL cholesterol level.
METHODS: In all, 241 consecutive patients presenting within 24 hours of ischemic stroke onset were evaluated with the National Institutes of Health Stroke Scale (NIHSS) and had fasting serum HDL levels collected the morning after admission. We determined the impact of low HDL cholesterol (<35 mg/dL) and age on median NIHSS score, controlling for the possible confounders.
RESULTS: Among the 241 patients, mean age was 69.5 years, 53% were male, and the median NIHSS score was 5 (range: 0-35). There was no association between low-serum HDL and NIHSS score at presentation for the overall group (6 v 5, P = .385). In young patients (</=50 years), low HDL level was associated with more severe stroke (NIHSS score 15 v 4, P = .005). The association of HDL with stroke severity remained significant after adjusting for all factors (13 v 2, P = .01).
CONCLUSION: Overall, low-serum HDL was not associated with stroke severity. There may be an association of higher serum HDL with reduced stroke severity in patients aged 50 years and younger.

Entities:  

Year:  2006        PMID: 17904074     DOI: 10.1016/j.jstrokecerebrovasdis.2006.05.003

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  7 in total

1.  Prognostic significance of major lipids in patients with acute ischemic stroke.

Authors:  Konstantinos Tziomalos; Vasilios Giampatzis; Stella D Bouziana; Marianna Spanou; Stavroula Kostaki; Maria Papadopoulou; Stella-Maria Angelopoulou; Maria Tsopozidi; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  Metab Brain Dis       Date:  2016-10-23       Impact factor: 3.584

Review 2.  The role of cholesterol and statins in stroke.

Authors:  Babak B Navi; Alan Z Segal
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

3.  Association of lipid profiles with severity and outcome of acute ischemic stroke in patients with and without chronic kidney disease.

Authors:  Ailing Zhang; Wenjing Deng; Bin Zhang; Mengyang Ren; Long Tian; Jihui Ge; Jinjuan Bai; Hao Hu; Ling Cui
Journal:  Neurol Sci       Date:  2020-10-13       Impact factor: 3.307

4.  Lipid Paradox in Statin-Naïve Acute Ischemic Stroke But Not Hemorrhagic Stroke.

Authors:  Kai-Hung Cheng; Jr-Rung Lin; Craig S Anderson; Wen-Ter Lai; Tsong-Hai Lee
Journal:  Front Neurol       Date:  2018-08-29       Impact factor: 4.003

5.  Cerebrovascular risk factors associated with ischemic stroke in a young non-diabetic and non-hypertensive population: a retrospective case-control study.

Authors:  Nan Zhang; Lin Zhang; Qiu Wang; Jingwei Zhao; Jia Liu; Guang Wang
Journal:  BMC Neurol       Date:  2020-11-23       Impact factor: 2.474

6.  Acute-Phase Stroke Outcome and Lipids.

Authors:  Osman Serhat Tokgoz; Figen Guney; Ahmet Kaya; Ahmet Bugrul; Esra Eruyar; Huseyin Buyukgol; Abdullah Seyithanoglu; Mehmet Sinan Iyisoy
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-12-29

7.  Related factors based on non-targeted metabolomics methods in minor ischaemic stroke.

Authors:  Chen Chen; Xiaoyuan Qiao; Jianyong Guo; Ting Yang; Min Wang; Yipeng Ma; Shuhe Zhao; Ling Ding; Hong Liu; Jintao Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-14       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.